New York, NY (PRWEB) March 25, 2015 -- A new analysis suggests that prescription low testosterone therapy (http://www.testosteronelawsuithub.com/) is frequently prescribed for men who have no medical need for such treatment. The study, which was published earlier this month in Public Health Reports, looked at insurance data from 61,474 men 40 years or older treated with testosterone replacement drugs from 2001 to 2010. Just over 19 percent received testosterone prescriptions despite having normal levels of the hormone. Only about 73 percent actually had their hormone levels tested before being prescribed testosterone therapy, while just over half had levels tested during the first year of treatment.*
“We find this analysis troubling, as it appears that the drugs are being prescribed to many men in ways that conflict with current treatment guidelines.** The study’s conclusions also echo concerns recently put forth by the FDA, which has been reviewing the cardiovascular side effects associated with low T therapy, regarding the extensive use of these medications to relieve low testosterone normally associated with aging,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free legal reviews to men who allegedly experienced heart attacks, strokes and other cardiovascular problems due to their use of testosterone replacement therapy.
Concerns Surrounding Testosterone Therapy
The FDA has been investigating the safety of low testosterone therapy since January 31, 2014, when it issued an alert detailing two studies which suggested the treatments might increase the risk for heart attack, stroke, and death in certain men.*** On March 3, 2015, the agency updated that alert, and announced that that new information would be added to the drug’s labels regarding their potential association with heart attacks and strokes. In addition, their labels would be modified to clarify current approved uses, as testosterone replacement is only indicated to treat men who suffer from hypogonadism (low testosterone levels) due to disorders of the testicles, pituitary gland, or brain. The FDA said it had become aware that prescription testosterone treatments were being used extensively to relieve symptoms in men who have low testosterone for no apparent reason other than aging. The agency noted that the benefits and safety of this use have not been established.
Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*ncbi.nlm.nih.gov/pubmed/25729103, Public Health Report, March-April 2015
**endocrine.org/~/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/FINAL-Androgens-in-Men-Standalone.pdf, Endocrine Society, 2010
**fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
Sandy A. Liebhard, Testosterone Lawsuit Legal Center, http://www.testosteronelawsuithub.com/, +1 800-511-5092, [email protected]
SOURCE Testosterone Lawsuit Legal Center